You are here
NOTICE OF EXTRAORDINARY GENERAL MEETING
27 November 2009: The Board of Directors of NorDiag ASA calls for an Extraordinary General Meeting [...]
The Board of Directors of NorDiag ASA calls for an Extraordinary General Meeting of NorDiag to be held on Friday 18 December 2009 at 10:00 hours CET at the company's office in Frysjaveien 40, entrance 12, 4rd floor, 0884 Oslo, Norway.
The agenda includes a proposal to increase the share capital of the company through a private placement and a repair issue, as well as a proposed adjustment of the terms of the Class B Warrants and the Class C Warrants. As a consequence of the proposed share capital increase, the Board of Directors further proposes certain changes in the option programme for management, employees and key personnel and a new board authorisation to increase the share capital. The Board of Directors also proposes certain amendments to the Articles of Association in accordance with the changes to the Public Limited Company Act that entered into force on 3 August 2009.
The complete notice of the Extraordinary General Meeting is attached.
Contact:
CEO Mårten Wigstøl - Phone: +47 911 65775
CFO Tone Kvåle - Phone: +47 915 19576
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and it is the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 40.1 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.
For further information - www.nordiag.com.
Participants in the private placement
Read the notice in Norwegian here.